Benzinga's Weekend M&A Chatter

Benzinga's M&A Chatter for Friday July 24 through Sunday July 26, 2015 The following are the M&A deals, rumors and chatter circulating on Wall Street for Friday July 20, 2015: Teva Said to Buy Allergan's Generic Drug Unit The Rumor:
Teva Pharmaceutical Industries Ltd. TEVA is in talks to merge with Allergan PLC's AGN generic drug unit, according to sources as reported by the Wall Street Journal. The Allergan unit would be spun off and combined with Teva. Teva has been attempting to acquire Mylan NV MYL, who in turn has been working on a deal to acquire Perrigo Co. PLC PRGO. Teva's acquisition of the Allergan business, in a deal valued at about $45 billion, could be announced as early as Monday. Teva closed at $61.85 on Friday, a loss of 1%. Allergan closed at $308.21 Friday, a loss of 2%. Allergan to Acquire Naurex for $560M in Cash The Deal:
Allergan plc AGN and Naurex Inc., announced Sunday, that Allergan will acquire Naurex for $560 million in an all-cash transaction. $460 million is payable upon the closing of the acquisition and $100 million is payable by January of 2016. The deal is expected to close by the end of 2015. Allergan shares closed at $308.21 Friday, a loss of 2%. Anthem to Acquire Cigna for $103.40 Cash, 0.5152 Shares For Each Cigna Share The Deal:
Anthem, Inc. ANTM and Cigna Corporation CI announced Friday, that Anthem will acquire all outstanding shares of Cigna for $103.40 in cash and 0.5152 Anthem common shares for each Cigna common share, or approximately $188.00 per share total consideration. The deal is expected to close in H2 of 2016. Cigna closed at $145.72 Friday, a loss of 5.5%. McGraw Hill Financial in Talks to Acquire SNL Financial The Rumor:
McGraw Hill Financial Inc. MHFI, the owner of Standard & Poors Ratings Services, is close to a deal to acquire SNL Financial, according to sources as reported by Bloomberg. The deal is said to be valued at more than $2 billion. Sources say the deal could be announced as early as Monday. McGraw Hill Financial closed at $105.58 on Monday, down $0.92.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsRumorsM&AMovers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!